Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study-Reference-Cited by-同舟云学术

Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study

Published:2015-10-06 Issue:1 Volume:10 Page:
ISSN:1940-0640
Container-title:Addiction Science & Clinical Practice
language:en
Short-container-title:Addict Sci Clin Pract

Author:

Bawor Monica,Dennis Brittany B.,Tan Charlie,Pare Guillaume,Varenbut Michael,Daiter Jeff,Plater Carolyn,Worster Andrew,Marsh David C.,Steiner Meir,Anglin Rebecca,Desai Dipika,Thabane Lehana,Samaan Zainab

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13722-015-0040-7

Reference57 articles.

1. Gomes T, Mamdani MM, Dhalla IA, Cornish S, Paterson JM, Juurlink DN. The burden of premature opioid-related mortality. Addiction. 2014;109(9):1482–8.

2. United Nations Office on Drugs and Crime: World Drug Report 2014. http://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf .

3. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med. 2009;361(8):777–86.

4. Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009; (3):CD002209.

5. Li Y, Kantelip JP, Gerritsen-van Schieveen P, Davani S. Interindividual variability of methadone response: impact of genetic polymorphism. Mol Diagn Ther. 2008;12(2):109–24.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring neuroadaptive cellular pathways in chronic morphine exposure: An in‐vitro analysis of cabergoline and Mdivi‐1 co‐treatment effects on the autophagy–apoptosis axis;Journal of Cellular Biochemistry;2024-04-05

2. Predictive Factors for Methadone Maintenance Treatment Compliance: Exploring Resistance and Tolerance in Heroin Addiction;Iranian Journal of Psychiatry and Behavioral Sciences;2024-03-04

3. Oxycodone withdrawal induces HDAC1/HDAC2-dependent transcriptional maladaptations in the reward pathway in a mouse model of peripheral nerve injury;Nature Neuroscience;2023-06-08

4. Sublingual buprenorphine/naloxone treatment is not affected by OPRM1 A118G and BDNF Va66Met polymorphisms, but alters the plasma beta-endorphin and BDNF levels in individuals with opioid use disorder;Environmental Toxicology and Pharmacology;2022-10

5. Reviewing pharmacogenetics to advance precision medicine for opioids;Biomedicine & Pharmacotherapy;2021-10